Hawaii Biotech, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 1982-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hibiotech.com
Study of HBV-001 D1 in Healthy Adults
Phase 1
Completed
- Conditions
- Dengue Fever
- Interventions
- Biological: DEN1-80E (HBV-001 D1 + 3.5 mg Alhydrogel)Biological: Placebo for DEN1-80E
- First Posted Date
- 2009-07-10
- Last Posted Date
- 2011-02-07
- Lead Sponsor
- Hawaii Biotech, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT00936429
- Locations
- 🇺🇸
Saint Louis University, St. Louis, Missouri, United States
Safety Study of HBV-002 West Nile Vaccine in Healthy Adults
Phase 1
Completed
- Conditions
- West Nile Virus Disease
- Interventions
- Biological: WN-80E
- First Posted Date
- 2008-07-01
- Last Posted Date
- 2009-06-16
- Lead Sponsor
- Hawaii Biotech, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT00707642
- Locations
- 🇺🇸
Covance Clinical Research Unit, Honolulu, Hawaii, United States
© Copyright 2025. All Rights Reserved by MedPath